Merit Medical Systems Free Cash Flow 2012-2026 | MMSI
Merit Medical Systems free cash flow from 2012 to 2026. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Merit Medical Systems Annual Free Cash Flow | |
|---|---|
| 2025 | |
| 2024 | 185.66 |
| 2023 | 111.06 |
| 2022 | 69.33 |
| 2021 | 120.33 |
| 2020 | 119.32 |
| 2019 | 0.56 |
| 2018 | 23.26 |
| 2017 | 24.13 |
| 2016 | 20.78 |
| 2015 | 19.75 |
| 2014 | 19.24 |
| 2013 | -8.02 |
| 2012 | -17.66 |
| 2011 | -25.18 |
| Merit Medical Systems Quarterly Free Cash Flow | |
|---|---|
| 2026-03-31 | |
| 2025-12-31 | |
| 2025-09-30 | 141.66 |
| 2025-06-30 | 89.11 |
| 2025-03-31 | 19.51 |
| 2024-12-31 | 185.66 |
| 2024-09-30 | 120.39 |
| 2024-06-30 | 82.42 |
| 2024-03-31 | 24.53 |
| 2023-12-31 | 111.06 |
| 2023-09-30 | 55.93 |
| 2023-06-30 | 13.48 |
| 2023-03-31 | 1.96 |
| 2022-12-31 | 69.33 |
| 2022-09-30 | 53.81 |
| 2022-06-30 | 34.09 |
| 2022-03-31 | 2.48 |
| 2021-12-31 | 120.33 |
| 2021-09-30 | 82.84 |
| 2021-06-30 | 64.51 |
| 2021-03-31 | 29.93 |
| 2020-12-31 | 119.32 |
| 2020-09-30 | 92.80 |
| 2020-06-30 | 47.44 |
| 2020-03-31 | 14.91 |
| 2019-12-31 | 0.56 |
| 2019-09-30 | -6.94 |
| 2019-06-30 | -0.25 |
| 2019-03-31 | -4.75 |
| 2018-12-31 | 23.26 |
| 2018-09-30 | 15.84 |
| 2018-06-30 | 3.49 |
| 2018-03-31 | -8.30 |
| 2017-12-31 | 24.13 |
| 2017-09-30 | 13.88 |
| 2017-06-30 | 16.79 |
| 2017-03-31 | 5.00 |
| 2016-12-31 | 20.78 |
| 2016-09-30 | 9.85 |
| 2016-06-30 | 4.22 |
| 2016-03-31 | 0.59 |
| 2015-12-31 | 19.75 |
| 2015-09-30 | 17.55 |
| 2015-06-30 | 15.02 |
| 2015-03-31 | 9.78 |
| 2014-12-31 | 19.24 |
| 2014-09-30 | 7.39 |
| 2014-06-30 | 1.44 |
| 2014-03-31 | -0.73 |
| 2013-12-31 | -8.02 |
| 2013-09-30 | -14.34 |
| 2013-06-30 | -15.97 |
| 2013-03-31 | -17.06 |
| 2012-12-31 | -17.66 |
| 2012-09-30 | -17.09 |
| 2012-06-30 | -13.18 |
| 2012-03-31 | -10.25 |
| 2011-12-31 | -25.18 |
| 2011-09-30 | -8.37 |
| 2011-06-30 | -8.04 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $4.072B | $1.516B |
| Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |